Emmaus Life Sciences EMMA Estimates

OTC EMMA
$0.05 -0.01 (-16.67%)
At close: Oct 19, 2026 · 4:00 PM EDT
Analyst Estimates

Emmaus Life Sciences, Inc. Revenue Estimates

Periods 13
Next Period Q1 24
Consensus 5.23 M

Analysts expect Emmaus Life Sciences, Inc. to report revenue of 5.23 M for Q1 24, against a range of 4.71 M to 5.75 M. The most recent reported quarter, Q2 26, came in at 6.32 M, a 4.7% miss against the 6.63 M consensus.

Metric Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Reported (Actual) 7.07 M-5.38 M---2.82 M3.38 M3.85 M1.98 M6.32 M--
High Estimate 5.62 M5.75 M5.62 M4.91 M6.73 M6.40 M8.51 M7.83 M8.52 M6.08 M7.10 M6.39 M7.25 M
Low Estimate 4.98 M4.71 M5.03 M4.50 M5.61 M6.00 M7.60 M6.72 M7.29 M5.11 M6.16 M5.70 M6.49 M
Consensus Estimate 5.30 M5.23 M5.33 M4.71 M6.17 M6.20 M8.06 M7.28 M7.90 M5.59 M6.63 M6.05 M6.87 M
Analyst Estimates

Emmaus Life Sciences, Inc. Earnings Per Share (EPS) Estimates

Periods 16
Next Period Q1 24
Consensus 0.01

Analysts expect Emmaus Life Sciences, Inc. to report earnings per share of 0.01 for Q1 24, against a range of 0.01 to 0.01. The most recent reported quarter, Q2 26, came in at 0.02, a 4.6% miss against the 0.02 consensus.

Metric Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Reported (Actual) -0.07-0.03-0.010.04--0.03----0.02-0.03-0.03-0.050.02--
High Estimate -0.03-0.03-0.040.030.010.010.010.010.02-0.010.020.020.060.020.050.02
Low Estimate -0.03-0.03-0.040.030.010.010.010.010.02-0.010.020.020.060.020.050.02
Consensus Estimate -0.03-0.03-0.040.030.010.010.010.010.02-0.010.020.020.060.020.050.02

Emmaus Life Sciences, Inc. Estimates API

Pull Wall Street consensus for Emmaus Life Sciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=EMMA&mode=revenue&api_key=YOUR_API_KEY